Biblio Discovery — Demo Discovery Service

9 hasil untuk "K. Mehta"

Menampilkan 1–9 · 3,47 detik · RSS

  1. Artikel Jurnal

    US life expectancy stalls due to cardiovascular disease, not drug deaths

    Neil K. Mehta; Leah R. Abrams; Mikko Myrskylä

    Proceedings of the National Academy of Sciences · 2020 · Inggris · OpenAlex Scopus

    After decades of robust growth, the rise in US life expectancy stalled after 2010. Explanations for the stall have focused on rising drug-related deaths. Here we show that a stagnating decline in cardiovascular disease (CVD) mortality was the main culprit, outpacing and overshadowing the effects of…

  2. Artikel Jurnal Teks lengkap

    Integrated optical multi-ion quantum logic

    Karan K. Mehta; Chi Zhang; Maciej Malinowski dkk.

    Nature · 2020 · Inggris · OpenAlex Scopus

  3. Artikel Jurnal

    Materials challenges and opportunities for quantum computing hardware

    Nathalie P. de Leon; Kohei M. Itoh; Dohun Kim dkk.

    Science · 2021 · Inggris · OpenAlex Scopus

    Quantum computing hardware technologies have advanced during the past two decades, with the goal of building systems that can solve problems that are intractable on classical computers. The ability to realize large-scale systems depends on major advances in materials science, materials engineering…

  4. Artikel Jurnal Teks lengkap

    Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women

    Harmony R. Reynolds; Akiko Maehara; Raymond Y.K. Kwong dkk.

    Circulation · 2020 · Inggris · OpenAlex Scopus

    Background: Myocardial infarction with nonobstructive coronary arteries (MINOCA) occurs in 6% to 15% of myocardial infarctions (MIs) and disproportionately affects women. Scientific statements recommend multimodality imaging in MINOCA to define the underlying cause. We performed coronary optical…

  5. Artikel Jurnal

    Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells

    Kristen W. Cohen; Susanne L. Linderman; Zoe Moodie dkk.

    Cell Reports Medicine · 2021 · Inggris · OpenAlex Scopus

    Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life…

  6. Artikel Jurnal

    Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

    Mehul S. Suthar; Matthew G. Zimmerman; Robert C. Kauffman dkk.

    Cell Reports Medicine · 2020 · Inggris · OpenAlex Scopus

    SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide pandemic, and there is a pressing need to understand the development, specificity, and neutralizing potency of humoral immune responses during acute infection. We report a cross-sectional study of antibody responses…

  7. Artikel Jurnal Teks lengkap

    Remdesivir for the Treatment of Covid-19 — Final Report

    John H. Beigel; Kay M Tomashek; Lori Elizabeth Dodd dkk.

    New England Journal of Medicine · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who…

  8. Artikel Jurnal

    Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

    André C. Kalil; Thomas F. Patterson; Aneesh K. Mehta dkk.

    New England Journal of Medicine · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: Severe coronavirus disease 2019 (Covid-19) is associated with dysregulated inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, plus remdesivir are not known. METHODS: We conducted a double-blind, randomized, placebo-controlled trial evaluating…